Test Price
2,800 AEDโ Home Collection Available
PNPT1 Gene Combined Oxidative Phosphorylation Deficiency Type 13 Genetic Test in UAE
Executive Summary & Core Metrics
Core Diagnostic Profile
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by our DHA-licensed clinicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PNPT1 gene analysis via Next-Generation Sequencing (NGS) provides a definitive molecular diagnosis for Combined Oxidative Phosphorylation Deficiency Type 13, enabling personalized clinical management and genetic counselling.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity (NGS with full gene coverage) | Sanger sequencing endpoint PCR (lower sensitivity for mosaicism) |
| Methodology | Next-Generation Sequencing (NGS) with bioinformatics pipeline aligned to DHA standards | Sanger sequencing (single exon analysis) |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks (typical) |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics, I emphasize that this genetic test must be interpreted in correlation with the patientโs clinical phenotype, family history, and biochemical findings. A negative result does not exclude other mitochondrial disorders, and incidental findings require careful genetic counselling. I strongly advise against making any medical decisions without discussing the results with your treating physician,โ says Lina Osama Zaki Quteineh (DHA Registration ID: 9294403).
Advisory & Sample Handling Guidelines
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients with decompensated metabolic crisis or acute hospitalization should postpone testing until clinically stable.
- Exclusion: Inadequate sample (hemolysed blood, insufficient DNA) requires recollection.
- Emergency Red Flags: If a patient exhibits sudden neurological deterioration (seizures, loss of consciousness, stroke-like episodes) following sample collection, seek immediate emergency care and inform the laboratory at +971545488731.
Important Medication Advisory
โ Do not discontinue prescribed medications or alter treatment regimens without consulting your doctor. This genetic test is for diagnostic purposes and should not replace ongoing clinical management.
Patient FAQ & Clinical Guidance
1. What is the PNPT1 gene test, and why is it ordered?
The PNPT1 NGS test sequences the entire PNPT1 gene to identify variants causing Combined Oxidative Phosphorylation Deficiency Type 13, a disorder that impairs cellular energy production. It is ordered when a patient presents with unexplained neurological, muscular, or metabolic symptoms suggestive of mitochondrial disease, or for family screening.
2. How should I prepare for the test, and is there any risk?
Sample collection involves a standard blood draw performed by a DHA-licensed phlebotomist. No fasting or medication alterations are necessary; however, a pre-test genetic counselling session is required to document family history. The procedure is minimally invasive with no significant risk.
3. What does a positive or negative result mean for my health?
A positive result confirms a pathogenic variant in PNPT1, enabling definitive diagnosis and guiding treatment and family planning. A negative result reduces likelihood of this specific subtype but does not rule out other genetic conditions. Results must be discussed with your physician to ensure appropriate clinical correlation and management.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, processed within secure UAE servers, and accessible only to authorized medical personnel. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | PNPT1 Gene Combined Oxidative Phosphorylation Deficiency Type 13 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available. |
| Methodology Used | Next-Generation Sequencing (NGS) with full gene coverage |
| ICD-10-CM Code | E88.49 |
| LOINC Code | 92988-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians